EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PLGA Microparticles as a Stable and Biocompatible Carrier for Adiponectin Delivery to Enhance Bone Regeneration

Pengxin Zhang, Yang Wang iD, Fan Hu, Yanping Gong iD

Pharmaceutics · 29.04.2026 · 18 (5) · 546

DOI: 10.3390/pharmaceutics18050546 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 29.04.2026. Verfasst von Pengxin Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The Second Medical Center, The Chinese People's Liberation Army General Hospital, Beijing 100853, China. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Project, Medical Science and Technology Youth Cultivation Program, Research Project on Chronic Disease Management of the Capacity Building and Continuing Ed-ucation Center of the National Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adiponectin (ADPN) is a key adipokine with osteogenic potential, but its clinical translation for bone regeneration is hindered by poor in vivo stability. This study aimed to develop poly lactic-co-glycolic acid (PLGA) microparticles as a stable and biocompatible carrier for sustained ADPN delivery to enhance bone repair.

Methods

ADPN-loaded PLGA microparticles (ADPN-MPs) were fabricated via emulsion solvent evaporation. Their physicochemical properties were characterized using scanning electron microscopy (SEM) and circular dichroism (CD) spectroscopy. Loading efficiency and drug loading were quantified. In vitro release kinetics and stability under physiological conditions were assessed. Biocompatibility was evaluated using MC3T3-E1 osteoblasts and BMSCs, and in vivo efficacy was tested in a fracture model via gait analysis.

Results

Employing CD to evaluate the secondary structure of ADPN, emulsion solvent evaporation for microparticles preparation, and SEM for morphological analysis, we quantitatively assessed the loading efficiency (69.83 ± 4.24%) and drug loading (0.97 ± 0.06%) of ADPN-MPs. Results indicated that ADPN-MPs maintained significant stability under varied pH and temperature conditions and exhibited a controlled release profile, with an average initial rapid release of 14.25% within 24 h and an average cumulative release of 55.00% by day 28. Furthermore, ADPN-MPs promoted the proliferation of MC3T3-E1 and BMSCs without toxicity, demonstrating excellent biocompatibility. Notably, gait analysis in a fracture model showed improved healing in both ADPN and ADPN-MPs groups compared to controls, with ADPN-MPs demonstrating comparable efficacy to free ADPN, supporting its potential as a stable delivery system for bone regeneration.

Conclusions

PLGA microparticles serve as an effective, stable, and biocompatible delivery platform for ADPN, significantly promoting bone regeneration in vitro and in vivo. This delivery system enhances the therapeutic potential of ADPN for clinical bone repair applications.

Schlagwörter

Stichwörter der Autor:innen

PLGAadiponectinbiocompatibilitybone regenerationmicroparticles

Autor:innen und Institutionen

  • Department of Endocrinology, The Second Medical Center, The Chinese People's Liberation Army General Hospital, Beijing 100853, China.
  • National Clinical Medical Research Center for Geriatric Diseases, The Chinese People's Liberation Army General Hospital, Beijing 100853, China.
  • Graduate School of the Chinese People's Liberation Army General Hospital, Beijing 100853, China.

ORCID-Profile: Yang Wang, Yanping Gong

Förderung

  • Scientific Research Project
  • Medical Science and Technology Youth Cultivation Program
  • Research Project on Chronic Disease Management of the Capacity Building and Continuing Ed-ucation Center of the National Health Commission
  • Special Healthcare Research Project
  • Research Project on Chronic Disease Management of the Capacity Building and Continuing Education Center of the National Health Commission

Zitieren

APA

Zhang, P., Wang, Y., Hu, F., & Gong, Y. (2026). PLGA Microparticles as a Stable and Biocompatible Carrier for Adiponectin Delivery to Enhance Bone Regeneration. Pharmaceutics, 18(5), 546. https://doi.org/10.3390/pharmaceutics18050546

Vancouver

Zhang P, Wang Y, Hu F, Gong Y. PLGA Microparticles as a Stable and Biocompatible Carrier for Adiponectin Delivery to Enhance Bone Regeneration. Pharmaceutics. 2026;18(5):546. doi:10.3390/pharmaceutics18050546

BibTeX
@article{Zhang2026,
  author = {Zhang, Pengxin and Wang, Yang and Hu, Fan and Gong, Yanping},
  title = {PLGA Microparticles as a Stable and Biocompatible Carrier for Adiponectin Delivery to Enhance Bone Regeneration},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {5},
  pages = {546},
  doi = {10.3390/pharmaceutics18050546}
}
Kostenlos starten →